CHMP recommends EU approval of Roche’s Avastin for platinum-resistant recurrent ovarian cancer
27 June 2014 | By Roche
Roche announced that the EU Committee for Medicinal Products for Human Use recommended that the European Commission approve the use of Avastin® (bevacizumab)...